Telangana and Kerala Take Action Against Coldrif Cough Syrup
In a significant move to protect public health, Telangana has issued a ‘stop use notice’ for Coldrif cough syrup, following Kerala’s recent ban on the medication. The syrup has been under scrutiny after the tragic deaths of several children who allegedly consumed it.
The Kerala Ban: A Precautionary Move
Kerala announced the ban on Coldrif on Monday, citing the need to safeguard vulnerable populations. State health officials reported at least three child deaths linked to the syrup. Preliminary investigations suggest harmful contaminants or incorrect dosage formulations may be responsible.
State Health Minister Veena George emphasized, “The safety of our children is paramount. We cannot afford to take any risks. The ban is a precautionary measure until a thorough investigation is completed.”
Telangana’s ‘Stop Use Notice’
Following Kerala’s lead, Telangana’s Directorate of Public Health and Family Welfare issued a ‘stop use notice’ on Wednesday. The notice urges healthcare providers, pharmacists, and the public to discontinue using the syrup immediately.
Dr. G. Srinivasa Rao, Telangana’s Director of Public Health, stated, “We are taking proactive steps to ensure public safety while awaiting further details from central drug regulatory authorities.”
Central Government’s Investigation
The Union Health Ministry has directed the Central Drugs Standard Control Organization (CDSCO) to investigate Coldrif. The CDSCO will review the syrup’s composition, manufacturing process, and quality control measures. Samples have been sent to laboratories for testing.
A senior Health Ministry official said, “We are treating this issue with utmost seriousness. The health of our citizens, especially children, cannot be compromised.”
Public Outcry and Calls for Accountability
The deaths have sparked widespread outrage, with parents and advocacy groups demanding stricter drug safety protocols. Many are calling for more rigorous testing of medications before they reach the market.
Dr. Anjali Sharma, a pediatrician in Hyderabad, remarked, “This is not the first such incident. The government must ensure only safe and effective drugs are available.”
What’s Next?
Investigations are ongoing to identify the root cause of the adverse effects. State governments are urging citizens to consult healthcare professionals before administering medication to children.
This incident highlights the need for a stronger regulatory framework to prevent future tragedies. Transparent and swift action is essential to restore public trust in the healthcare system.
Stay updated with NextMinuteNews for further developments on this story.
